Quest Diagnostics Incorporated announced on April 27 the pricing of a public offering for $500 million in aggregate principal amount of its 5.000% senior notes due 2036. The company expects to receive the net proceeds from this offering upon closing, which is scheduled for May 6, subject to customary closing conditions.
The proceeds from the offering are expected to be used for general corporate purposes, which may include repayment of existing indebtedness. Specifically, Quest Diagnostics said it may use the funds to repay its $500 million aggregate principal amount of 3.45% Senior Notes maturing on June 1, 2026.
In its statement, Quest Diagnostics emphasized that “this press release shall not constitute an offer to sell or a solicitation of an offer to purchase any of these securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.” Information about obtaining prospectus supplements was also provided by the company.
The company describes itself as working across healthcare “to create a healthier world, one life at a time.” It states that it connects people with laboratory insights aimed at better health outcomes and serves half the physicians and hospitals in the United States as well as one in three American adults each year through nearly 57,000 employees.
Readers are cautioned by Quest Diagnostics that “the statements in this press release which are not historical facts may be forward-looking statements,” noting risks such as economic volatility and regulatory changes could affect future results. Further details can be found in their most recent annual and quarterly reports.
PR Newswire operates in more than 170 countries and supports distribution in over 40 languages according to its official website (official website). The organization aims to deliver global reach for press releases through a network involving newsrooms and influencers (official website). PR Newswire also features expert editors who provide around-the-clock support and SEO guidance (official website), collaborates with over half a million media outlets globally (official website), and offers services including AI-enhanced content tools along with social sharing features (official website).
Looking ahead, industry observers will watch how Quest Diagnostics uses these new funds within their broader strategy.
